nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Nucleoside Analog—Azathioprine—Crohn's disease	0.935	1	CiPCiCtD
Emtricitabine—Decitabine—DNMT3A—Crohn's disease	0.00393	1	CrCbGaD
Emtricitabine—Hepatitis B—Azathioprine—Crohn's disease	0.00342	0.0574	CcSEcCtD
Emtricitabine—Lipase increased—Mesalazine—Crohn's disease	0.00193	0.0325	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Mercaptopurine—Crohn's disease	0.00176	0.0296	CcSEcCtD
Emtricitabine—Buffalo hump—Prednisone—Crohn's disease	0.0015	0.0252	CcSEcCtD
Emtricitabine—Lipohypertrophy—Prednisone—Crohn's disease	0.00138	0.0231	CcSEcCtD
Emtricitabine—Rash generalised—Mesalazine—Crohn's disease	0.00134	0.0225	CcSEcCtD
Emtricitabine—Prurigo—Mesalazine—Crohn's disease	0.00123	0.0207	CcSEcCtD
Emtricitabine—Amylase increased—Mesalazine—Crohn's disease	0.00119	0.0201	CcSEcCtD
Emtricitabine—DCK—Desoximetasone—Prednisone—Crohn's disease	0.00086	0.507	CbGdCrCtD
Emtricitabine—Nephritis interstitial—Mesalazine—Crohn's disease	0.000842	0.0141	CcSEcCtD
Emtricitabine—DCK—Diflorasone—Prednisone—Crohn's disease	0.000834	0.493	CbGdCrCtD
Emtricitabine—Osteonecrosis—Prednisone—Crohn's disease	0.000807	0.0136	CcSEcCtD
Emtricitabine—Opportunistic infection—Prednisone—Crohn's disease	0.000746	0.0125	CcSEcCtD
Emtricitabine—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.000742	0.0125	CcSEcCtD
Emtricitabine—Rash pustular—Mesalazine—Crohn's disease	0.000712	0.012	CcSEcCtD
Emtricitabine—Breast disorder—Mercaptopurine—Crohn's disease	0.000687	0.0115	CcSEcCtD
Emtricitabine—Proteinuria—Mesalazine—Crohn's disease	0.000647	0.0109	CcSEcCtD
Emtricitabine—Pancreatitis—Mercaptopurine—Crohn's disease	0.000644	0.0108	CcSEcCtD
Emtricitabine—Protein urine present—Mesalazine—Crohn's disease	0.000638	0.0107	CcSEcCtD
Emtricitabine—Skin discolouration—Mesalazine—Crohn's disease	0.000629	0.0106	CcSEcCtD
Emtricitabine—Cough increased—Mesalazine—Crohn's disease	0.000621	0.0104	CcSEcCtD
Emtricitabine—Abnormal dreams—Mesalazine—Crohn's disease	0.000561	0.00944	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000554	0.00931	CcSEcCtD
Emtricitabine—Neuropathy—Mesalazine—Crohn's disease	0.000533	0.00897	CcSEcCtD
Emtricitabine—Hypertriglyceridaemia—Prednisone—Crohn's disease	0.000523	0.0088	CcSEcCtD
Emtricitabine—Multiple fractures—Prednisone—Crohn's disease	0.000517	0.00869	CcSEcCtD
Emtricitabine—Fracture—Prednisone—Crohn's disease	0.000517	0.00869	CcSEcCtD
Emtricitabine—Immune system disorder—Mercaptopurine—Crohn's disease	0.000475	0.00798	CcSEcCtD
Emtricitabine—Gastroenteritis—Mesalazine—Crohn's disease	0.000465	0.00782	CcSEcCtD
Emtricitabine—Blood triglycerides increased—Prednisone—Crohn's disease	0.000459	0.00771	CcSEcCtD
Emtricitabine—Malnutrition—Mercaptopurine—Crohn's disease	0.000458	0.00769	CcSEcCtD
Emtricitabine—Renal failure acute—Mesalazine—Crohn's disease	0.000447	0.00751	CcSEcCtD
Emtricitabine—Renal impairment—Mesalazine—Crohn's disease	0.000433	0.00728	CcSEcCtD
Emtricitabine—Dermatitis bullous—Mesalazine—Crohn's disease	0.000432	0.00725	CcSEcCtD
Emtricitabine—Myopathy—Prednisone—Crohn's disease	0.000429	0.00721	CcSEcCtD
Emtricitabine—Hepatomegaly—Prednisone—Crohn's disease	0.000425	0.00714	CcSEcCtD
Emtricitabine—Anaemia—Mercaptopurine—Crohn's disease	0.000423	0.00711	CcSEcCtD
Emtricitabine—Neuritis—Prednisone—Crohn's disease	0.000403	0.00677	CcSEcCtD
Emtricitabine—Arthralgia—Mercaptopurine—Crohn's disease	0.00039	0.00655	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000387	0.0065	CcSEcCtD
Emtricitabine—Blood creatinine increased—Mesalazine—Crohn's disease	0.000386	0.00649	CcSEcCtD
Emtricitabine—Pancreatitis—Azathioprine—Crohn's disease	0.000384	0.00645	CcSEcCtD
Emtricitabine—Breast disorder—Mesalazine—Crohn's disease	0.000373	0.00626	CcSEcCtD
Emtricitabine—Glycosuria—Prednisone—Crohn's disease	0.000371	0.00624	CcSEcCtD
Emtricitabine—Nasopharyngitis—Mesalazine—Crohn's disease	0.000369	0.0062	CcSEcCtD
Emtricitabine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000366	0.00615	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000364	0.00611	CcSEcCtD
Emtricitabine—Skin disorder—Mercaptopurine—Crohn's disease	0.000363	0.0061	CcSEcCtD
Emtricitabine—Pneumonia—Azathioprine—Crohn's disease	0.000351	0.0059	CcSEcCtD
Emtricitabine—Pancreatitis—Mesalazine—Crohn's disease	0.000349	0.00587	CcSEcCtD
Emtricitabine—Infestation—Azathioprine—Crohn's disease	0.000349	0.00587	CcSEcCtD
Emtricitabine—Infestation NOS—Azathioprine—Crohn's disease	0.000349	0.00587	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00034	0.00572	CcSEcCtD
Emtricitabine—Neutropenia—Mesalazine—Crohn's disease	0.000333	0.0056	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000331	0.00557	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00033	0.00555	CcSEcCtD
Emtricitabine—Weight decreased—Mesalazine—Crohn's disease	0.000322	0.00542	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000322	0.00542	CcSEcCtD
Emtricitabine—Pneumonia—Mesalazine—Crohn's disease	0.00032	0.00537	CcSEcCtD
Emtricitabine—Infestation—Mesalazine—Crohn's disease	0.000318	0.00534	CcSEcCtD
Emtricitabine—Infestation NOS—Mesalazine—Crohn's disease	0.000318	0.00534	CcSEcCtD
Emtricitabine—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000318	0.00534	CcSEcCtD
Emtricitabine—Depression—Mesalazine—Crohn's disease	0.000317	0.00533	CcSEcCtD
Emtricitabine—Renal failure—Mesalazine—Crohn's disease	0.000312	0.00525	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000312	0.00524	CcSEcCtD
Emtricitabine—Urinary tract infection—Mesalazine—Crohn's disease	0.000309	0.00519	CcSEcCtD
Emtricitabine—Haematuria—Mesalazine—Crohn's disease	0.000303	0.00509	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000301	0.00505	CcSEcCtD
Emtricitabine—Sinusitis—Mesalazine—Crohn's disease	0.000298	0.00501	CcSEcCtD
Emtricitabine—Body temperature increased—Mercaptopurine—Crohn's disease	0.000295	0.00496	CcSEcCtD
Emtricitabine—Rhinitis—Mesalazine—Crohn's disease	0.000286	0.00481	CcSEcCtD
Emtricitabine—Hepatitis—Mesalazine—Crohn's disease	0.000285	0.0048	CcSEcCtD
Emtricitabine—Pharyngitis—Mesalazine—Crohn's disease	0.000283	0.00476	CcSEcCtD
Emtricitabine—Immune system disorder—Azathioprine—Crohn's disease	0.000283	0.00476	CcSEcCtD
Emtricitabine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000282	0.00475	CcSEcCtD
Emtricitabine—Neuropathy—Prednisone—Crohn's disease	0.000282	0.00474	CcSEcCtD
Emtricitabine—Urinary tract disorder—Mesalazine—Crohn's disease	0.000282	0.00474	CcSEcCtD
Emtricitabine—Connective tissue disorder—Mesalazine—Crohn's disease	0.00028	0.00471	CcSEcCtD
Emtricitabine—Urethral disorder—Mesalazine—Crohn's disease	0.00028	0.0047	CcSEcCtD
Emtricitabine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000275	0.00463	CcSEcCtD
Emtricitabine—Immune system disorder—Mesalazine—Crohn's disease	0.000258	0.00433	CcSEcCtD
Emtricitabine—Mediastinal disorder—Mesalazine—Crohn's disease	0.000257	0.00432	CcSEcCtD
Emtricitabine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000256	0.0043	CcSEcCtD
Emtricitabine—Anaemia—Azathioprine—Crohn's disease	0.000252	0.00424	CcSEcCtD
Emtricitabine—Mental disorder—Mesalazine—Crohn's disease	0.00025	0.0042	CcSEcCtD
Emtricitabine—Back pain—Mesalazine—Crohn's disease	0.00024	0.00404	CcSEcCtD
Emtricitabine—Vomiting—Mercaptopurine—Crohn's disease	0.000237	0.00399	CcSEcCtD
Emtricitabine—Rash—Mercaptopurine—Crohn's disease	0.000235	0.00396	CcSEcCtD
Emtricitabine—Dermatitis—Mercaptopurine—Crohn's disease	0.000235	0.00395	CcSEcCtD
Emtricitabine—Arthralgia—Azathioprine—Crohn's disease	0.000232	0.0039	CcSEcCtD
Emtricitabine—Myalgia—Azathioprine—Crohn's disease	0.000232	0.0039	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000231	0.00388	CcSEcCtD
Emtricitabine—Anaemia—Mesalazine—Crohn's disease	0.00023	0.00386	CcSEcCtD
Emtricitabine—Angioedema—Mesalazine—Crohn's disease	0.000227	0.00381	CcSEcCtD
Emtricitabine—Nausea—Mercaptopurine—Crohn's disease	0.000222	0.00373	CcSEcCtD
Emtricitabine—Infection—Azathioprine—Crohn's disease	0.000221	0.00372	CcSEcCtD
Emtricitabine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000218	0.00366	CcSEcCtD
Emtricitabine—Cough—Mesalazine—Crohn's disease	0.000217	0.00364	CcSEcCtD
Emtricitabine—Skin disorder—Azathioprine—Crohn's disease	0.000216	0.00363	CcSEcCtD
Emtricitabine—Arthralgia—Mesalazine—Crohn's disease	0.000211	0.00355	CcSEcCtD
Emtricitabine—Myalgia—Mesalazine—Crohn's disease	0.000211	0.00355	CcSEcCtD
Emtricitabine—Anxiety—Mesalazine—Crohn's disease	0.000211	0.00354	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00021	0.00353	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000203	0.00341	CcSEcCtD
Emtricitabine—Infection—Mesalazine—Crohn's disease	0.000201	0.00339	CcSEcCtD
Emtricitabine—Nervous system disorder—Mesalazine—Crohn's disease	0.000199	0.00334	CcSEcCtD
Emtricitabine—Hypokalaemia—Prednisone—Crohn's disease	0.000199	0.00334	CcSEcCtD
Emtricitabine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000198	0.00334	CcSEcCtD
Emtricitabine—Skin disorder—Mesalazine—Crohn's disease	0.000197	0.00331	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000192	0.00323	CcSEcCtD
Emtricitabine—Muscular weakness—Prednisone—Crohn's disease	0.000192	0.00323	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000192	0.00323	CcSEcCtD
Emtricitabine—Pancreatitis—Prednisone—Crohn's disease	0.000185	0.00311	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000185	0.0031	CcSEcCtD
Emtricitabine—Insomnia—Mesalazine—Crohn's disease	0.000183	0.00308	CcSEcCtD
Emtricitabine—Paraesthesia—Mesalazine—Crohn's disease	0.000182	0.00306	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000182	0.00306	CcSEcCtD
Emtricitabine—Dyspnoea—Mesalazine—Crohn's disease	0.000181	0.00304	CcSEcCtD
Emtricitabine—Dyspepsia—Mesalazine—Crohn's disease	0.000178	0.003	CcSEcCtD
Emtricitabine—Neutropenia—Prednisone—Crohn's disease	0.000176	0.00296	CcSEcCtD
Emtricitabine—Abdominal pain—Azathioprine—Crohn's disease	0.000176	0.00296	CcSEcCtD
Emtricitabine—Body temperature increased—Azathioprine—Crohn's disease	0.000176	0.00296	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000175	0.00294	CcSEcCtD
Emtricitabine—Fatigue—Mesalazine—Crohn's disease	0.000175	0.00294	CcSEcCtD
Emtricitabine—Pain—Mesalazine—Crohn's disease	0.000173	0.00291	CcSEcCtD
Emtricitabine—Weight decreased—Prednisone—Crohn's disease	0.000171	0.00287	CcSEcCtD
Emtricitabine—Hyperglycaemia—Prednisone—Crohn's disease	0.00017	0.00286	CcSEcCtD
Emtricitabine—Depression—Prednisone—Crohn's disease	0.000168	0.00282	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000166	0.00279	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000165	0.00277	CcSEcCtD
Emtricitabine—Hypersensitivity—Azathioprine—Crohn's disease	0.000164	0.00276	CcSEcCtD
Emtricitabine—Urticaria—Mesalazine—Crohn's disease	0.000161	0.00271	CcSEcCtD
Emtricitabine—Abdominal pain—Mesalazine—Crohn's disease	0.00016	0.00269	CcSEcCtD
Emtricitabine—Body temperature increased—Mesalazine—Crohn's disease	0.00016	0.00269	CcSEcCtD
Emtricitabine—Diarrhoea—Azathioprine—Crohn's disease	0.000152	0.00256	CcSEcCtD
Emtricitabine—Hypersensitivity—Mesalazine—Crohn's disease	0.000149	0.00251	CcSEcCtD
Emtricitabine—Connective tissue disorder—Prednisone—Crohn's disease	0.000148	0.00249	CcSEcCtD
Emtricitabine—Dizziness—Azathioprine—Crohn's disease	0.000147	0.00247	CcSEcCtD
Emtricitabine—Asthenia—Mesalazine—Crohn's disease	0.000145	0.00244	CcSEcCtD
Emtricitabine—Pruritus—Mesalazine—Crohn's disease	0.000143	0.00241	CcSEcCtD
Emtricitabine—Vomiting—Azathioprine—Crohn's disease	0.000141	0.00238	CcSEcCtD
Emtricitabine—Rash—Azathioprine—Crohn's disease	0.00014	0.00236	CcSEcCtD
Emtricitabine—Dermatitis—Azathioprine—Crohn's disease	0.00014	0.00236	CcSEcCtD
Emtricitabine—Headache—Azathioprine—Crohn's disease	0.000139	0.00234	CcSEcCtD
Emtricitabine—Diarrhoea—Mesalazine—Crohn's disease	0.000139	0.00233	CcSEcCtD
Emtricitabine—Immune system disorder—Prednisone—Crohn's disease	0.000136	0.00229	CcSEcCtD
Emtricitabine—Dizziness—Mesalazine—Crohn's disease	0.000134	0.00225	CcSEcCtD
Emtricitabine—Mental disorder—Prednisone—Crohn's disease	0.000132	0.00222	CcSEcCtD
Emtricitabine—Nausea—Azathioprine—Crohn's disease	0.000132	0.00222	CcSEcCtD
Emtricitabine—Malnutrition—Prednisone—Crohn's disease	0.000131	0.00221	CcSEcCtD
Emtricitabine—Vomiting—Mesalazine—Crohn's disease	0.000129	0.00217	CcSEcCtD
Emtricitabine—Rash—Mesalazine—Crohn's disease	0.000128	0.00215	CcSEcCtD
Emtricitabine—Dermatitis—Mesalazine—Crohn's disease	0.000128	0.00215	CcSEcCtD
Emtricitabine—Headache—Mesalazine—Crohn's disease	0.000127	0.00213	CcSEcCtD
Emtricitabine—Anaemia—Prednisone—Crohn's disease	0.000121	0.00204	CcSEcCtD
Emtricitabine—Nausea—Mesalazine—Crohn's disease	0.00012	0.00202	CcSEcCtD
Emtricitabine—Angioedema—Prednisone—Crohn's disease	0.00012	0.00202	CcSEcCtD
Emtricitabine—Arthralgia—Prednisone—Crohn's disease	0.000112	0.00188	CcSEcCtD
Emtricitabine—Myalgia—Prednisone—Crohn's disease	0.000112	0.00188	CcSEcCtD
Emtricitabine—Anxiety—Prednisone—Crohn's disease	0.000111	0.00187	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000111	0.00187	CcSEcCtD
Emtricitabine—Infection—Prednisone—Crohn's disease	0.000107	0.00179	CcSEcCtD
Emtricitabine—Nervous system disorder—Prednisone—Crohn's disease	0.000105	0.00177	CcSEcCtD
Emtricitabine—Skin disorder—Prednisone—Crohn's disease	0.000104	0.00175	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Prednisone—Crohn's disease	9.77e-05	0.00164	CcSEcCtD
Emtricitabine—Insomnia—Prednisone—Crohn's disease	9.7e-05	0.00163	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisone—Crohn's disease	9.63e-05	0.00162	CcSEcCtD
Emtricitabine—Dyspepsia—Prednisone—Crohn's disease	9.44e-05	0.00159	CcSEcCtD
Emtricitabine—Fatigue—Prednisone—Crohn's disease	9.25e-05	0.00155	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Prednisone—Crohn's disease	8.77e-05	0.00147	CcSEcCtD
Emtricitabine—Urticaria—Prednisone—Crohn's disease	8.52e-05	0.00143	CcSEcCtD
Emtricitabine—Body temperature increased—Prednisone—Crohn's disease	8.48e-05	0.00143	CcSEcCtD
Emtricitabine—Abdominal pain—Prednisone—Crohn's disease	8.48e-05	0.00143	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisone—Crohn's disease	7.9e-05	0.00133	CcSEcCtD
Emtricitabine—Asthenia—Prednisone—Crohn's disease	7.69e-05	0.00129	CcSEcCtD
Emtricitabine—Pruritus—Prednisone—Crohn's disease	7.59e-05	0.00128	CcSEcCtD
Emtricitabine—Diarrhoea—Prednisone—Crohn's disease	7.34e-05	0.00123	CcSEcCtD
Emtricitabine—Dizziness—Prednisone—Crohn's disease	7.09e-05	0.00119	CcSEcCtD
Emtricitabine—Vomiting—Prednisone—Crohn's disease	6.82e-05	0.00115	CcSEcCtD
Emtricitabine—Rash—Prednisone—Crohn's disease	6.76e-05	0.00114	CcSEcCtD
Emtricitabine—Dermatitis—Prednisone—Crohn's disease	6.76e-05	0.00114	CcSEcCtD
Emtricitabine—Headache—Prednisone—Crohn's disease	6.72e-05	0.00113	CcSEcCtD
Emtricitabine—Nausea—Prednisone—Crohn's disease	6.37e-05	0.00107	CcSEcCtD
